摩根大通医疗保健大会 2026（JPM2026）演讲PPT合集（共158套打包）

更新时间：2026-01-20 报告数量：158份

摩根大通医疗保健大会 2026（JPM2026）演讲PPT合集

全部

摩根大通医疗保健大会 2026（JPM2026）演讲PPT合集

报告合集目录

报告预览

全部
- 摩根大通医疗保健大会 2026（JPM2026）演讲PPT合集
  - ZTS_JPM_2026_Healthcare_Conference_Presentation.pdf
  - VRTX JPM 2026 Presentation_vFINAL.pdf
  - Teva-JPM-2026-presentation.pdf
  - Smith & Nephew-2026-JPM.pdf
  - Revolution Medicine-2026-JPM.pdf
  - Olympus-44th_J.P._Morgan_Healthcare_Conference.pdf
  - Merck Group-2026_JPM_Presentation_CEO_website_FINAL_EN.pdf
  - JPM 2026 Deck - PTCT - 1.9.26-FINAL - PDF.pdf
  - Henlius-JPM2026-Presentation.pdf
  - GEHC JPM 2026 Slides_FINAL.pdf
  - ELAN-JPM-2026-Presentation.pdf
  - Crinetics Pharmaceuticals-2026-JPM.pdf
  - Boston Scientific-jp-morgan-healthcare-conference-2025.pdf
  - BillionToOne - JPM Presentation 2026.pdf
  - Astellas_44th_JPMorgan_Healthcare_Conference_presentation_20260112_unlocked.pdf
  - Agios-JPM 2026_presentation_14 January 2026.pdf
  - Xenon-2026-JPM.pdf
  - Waters_2026_JPM_Investor-Presentation.pdf
  - ZaiLab-en-JPM 2026 Presentation_vFinal.pdf
  - UCB-2026-JPM.pdf
  - WuXi XDC-JPM2026-Slides.pdf
  - TGTX- JP Morgan Presentation 1.13.26v2.pdf
  - UPB_JPM2026_Presentation_FINAL.pdf
  - Tango Therapeutics-2026-JPM.pdf
  - Sotera Health-2026-JPM.pdf
  - TransMedics J.P. Morgan 2026 Presentation.pdf
  - Tempus AI JPM 2026.pdf
  - RYTM_January2026v_jpm.pdf
  - Summit Therapeutics-JPM-2026-Investor-Deck.pdf
  - Precigen_January 2026.pdf
  - Roche 20260111_jpm_finalf.pdf
  - novartis-investor-presentation-jpm-2026-growth-story.pdf
  - PacBio JPM 2026 Presentation.pdf
  - Lonza-2026-JPM.pdf
  - Inventiva-2026-JPM.pdf
  - Molecular Partners_JPM2026_CorporatePresentation_R.pdf
  - Ypsomed_JPM_Healthcare_Conference_clean.pdf
  - KRYS Corporate Deck - JPM 2026 vFinal.pdf
  - Immunome-Investor-Presentation-January-2026.pdf
  - Wave Life Sciences-2026-JPM.pdf
  - United Therapeutics-2026-JPM- Corporation.pdf
  - THERMOFISHER-TMO-Final-JPM-Presentation-as-of-01-08-26.pdf
  - Telix-20260112 JP Morgan Presentation vFINAL (1) 1.pdf
  - Stoke Therapeutics-2026-JPM.pdf
  - Sandoz-JPM-2026-Conference-Presentation.pdf
  - Revvity-JPM-2026.pdf
  - Prime Medicine Corporate Presentation _JPM Corporate Presentation.pdf
  - NVAX JPM Corporate Presentation January 2026.pdf
  - Madrigal Pharmaceuticals-2026-JPM.pdf
  - Ionis-2026_01_14_JPMorgan_Presentation.pdf
  - WXB-JPM26-deck_CH-FFF.pdf
  - Twist JPM 1-11-26 FINAL pdf_1.pdf
  - Takeda-武田-2026-JPM.pdf
  - Royalty Pharma-2026-JPM.pdf
  - Pfizer-Investor-Overview-at-2026-JPM-vFINAL2.pdf
  - Zimmer biomet-jp-morgan-presentation-2026.pdf
  - Wuxi-2026 JPM Presentation - WuXi AppTec 20260114.pdf
  - Vericel Company Presentation - JPMorgan Healthcare Conference January 14 2026 FINAL No Speaker Notes.pdf
  - Treace-JPM 2026 slides.pdf
  - Terumo-2026-JPM.pdf
  - Syndax-2026-JPM.pdf
  - siemens-healthineers-ir-2026_01_13_JPM-conf-SHL-presentation.pdf
  - Roivant Sciences-2026-JPM.pdf
  - Regeneron-JPM 2026 Presentation - FINAL.pdf
  - Pacira-2026-JPM.pdf
  - Oculis-2026-JPM.pdf
  - MRK-2026-JP-Morgan-Presentation.pdf
  - Medtronic-2026-JPM.pdf
  - Legend Biotech -2026 JP Morgan Presentation.pdf
  - JAZZ 2026 JPM Healthcare Conference Presentation_FINAL.pdf
  - Hengrui-第44届摩根大通年度健康医疗大会-恒瑞医药演讲.pdf
  - Oneness-2026_JPM_Oneness_full_version-0115_final_en_unlocked.pdf
  - Mereo-jp-morgan-presentation-january-2026.pdf
  - Sarepta Therapeutics 2026 JPMorgan Conference.pdf
  - Kelun-Biotech_2026_JPMHC_Final.pdf
  - Qiagen-20260112-JPM-slide-deck-FINAL.pdf
  - Illumina-JPM-Conference-January-2026.pdf
  - NVDA_JPM_Healthcare-2026.pdf
  - GRAIL JPM26_GRAIL presentation_Final_Jan 12 2025.pdf
  - McKesson-2026-JPM.pdf
  - GeneDx J.P. Morgan 2026 Healthcare Conference Presentation.pdf
  - Ipsen-JPM-Jan-2026-Investor-Presentation.pdf
  - Esperion-2026-JPM.pdf
  - HealthEquity-2026-JPM.pdf
  - Element JPM 2026 V3_Public_With-Notes_2 1.pdf
  - Genmab-2026-JPM.pdf
  - Disc JPM Final Presentation_2026.pdf
  - EYPT JPM2026 Presentation_vF.pdf
  - CytomX Therapeutics-2026_JPM_CTMX_Presentation_Website.pdf
  - Emergent-2026 JPM Presentation_1.14.26FINAL.pdf
  - Coherus BioSciences-2026 JP Morgan Presentation.pdf
  - Ono Pharmaceutical -2026-JPM.pdf
  - Dyne-2026-JPM.pdf
  - BridgeBio-JPM-2026-Presentation_vF.pdf
  - Dentsply Sirona 2026 JPM Healthcare Conference Presentation.pdf
  - Moderna+2026+JPM+Presentation_1.9.26_FINAL+for+web+upload-78-.pdf
  - Compass-2026-JPM.pdf
  - Kiniksa-2026-JPM.pdf
  - BioNTech-JPM Presentation 2026 WEBSITE version 1.pdf
  - Caris JPM Investor PresentationvF.pdf
  - IMCR Corporate Deck January 2026 13Jan2026.pdf
  - Baxter-J-P-Morgan-Conference-Presentation.pdf
  - Biohaven-2026-JPM.pdf
  - HARMONY JPM 2026 PRESENTATION NO BUILDS for Web -FINAL.pdf
  - APLS JPM 2026 Presentation_for website.pdf
  - Natera-JPM-Slides-2026-Final.pdf
  - AVITA Medical JP Morgan 2026.pdf
  - Acadia-JPM-Presentation-2026_For-Portal-Upload-01-10-26.pdf
  - Genfit-2026-JPM.pdf
  - ALNY_JPM26_PRESENTATION_01.12.2026.pdf
  - Liquidia-2026-JPM.pdf
  - Integra LifeSciences-2026 JPM.pdf
  - Exelixis-2026-JPM.pdf
  - 2026-TXG-JPM-Healthcare-Presentation-01-12-2026.pdf
  - Incyte_DECK_JPM_2026_2026_01_12_FINAL.pdf
  - Eli Lilly JPM 2026 Fireside Chat.pdf
  - GILD-JP-Morgan-Presentation-12-January-2026.pdf
  - Dizal -J.P. Morgan 44th Annual Healthcare Conference - Dizal Presentation_unlocked.pdf
  - Erasca Corporate Presentation_2026-01.pdf
  - DAIICHI SANKYO-202601_JPM Conference_slide.pdf
  - GH-JPM-2026-Presentation.pdf
  - Fujifilm-2026-JPM.pdf
  - CommonSpirit Health-2026-JPM.pdf
  - Dianthus Therapeutics-2026-JPM.pdf
  - ENOV 2026 JPM Deck_FINAL.pdf
  - chugai-JPM 2026.pdf
  - BRKR-JPM26-Presentation-Final.pdf
  - Biomea-2026-JPM.pdf
  - Edgewise Therapeutics-2026-JPM.pdf
  - Bioventus-2026-JPM.pdf
  - Dexcom-JPMorgan-Conference-Deck_Shared-Master_FINAL.pdf
  - Bausch & Lomb-2026-JPM.pdf
  - Bayer-2026-JPM.pdf
  - Argenx-2026_JPM_Conference_Slides_argenx.pdf
  - Connect Biopharma-2026-JPM.pdf
  - celltrion-Company Presentation at the J.P. Morgan Healthcare Conference 2026.pdf
  - ACHC_JPM2026_Deck_vFinal.pdf
  - Bora Pharmaceuticals_2026 44th JPM conference_CH.pdf
  - BioMarin_JPM-2026_FINAL_Jan-12.pdf
  - BeOne-JPM_2026_Presentation_CN.pdf
  - AZ-JPM-2026-Presentation.pdf
  - Ascentage Corporate Presentation_Vfinal jpm.pdf
  - Amgen-2026 JP Morgan Healthcare Conference Presentation (01.12.26 0900AM).pdf
  - Agilent-2026-JP-Morgan-Conference-Presentation.pdf
  - BioCryst Pharmaceuticals-2026-JPM.pdf
  - Atea-2026-JPM.pdf
  - Alcon Vision LLC-2026-JPM.pdf
  - BMS-JPM-2026-Presentation.pdf
  - Beam JPM deck_FINAL WEBSITE_260111.pdf
  - Ascendis-2026 JPM Presentation - Final.pdf
  - ADPT JPM2026 Presentation.pdf
  - AMRX-2026-JPM-Presentation.pdf
  - Absci JPM 2026 Presentation.pdf
  - Biogen-2026-JPM.pdf
  - Avantor_2026-JPM-HC-Conference-Presentation_vFINAL4.pdf
  - ALKS JPM Presentation 2026 FINAL.pdf
  - 2026 Danaher at JPM Healthcare.pdf
  - 20260109 CRISPR Therapeutics - JPM 2026.pdf

请点击导航文件预览

资源包简介：

1、44TH ANNUAL J.P.MORGAN HEALTHCARE CONFERENCELeading the Future of Animal Health January 12,20262Forward-Looking StatementsThis presentation contains forward-looking statements,which reflect the curre。

2、2026 Vertex Pharmaceuticals Incorporated2026 Vertex Pharmaceuticals IncorporatedJ.P.Morgan Healthcare ConferenceJanuary 2026Reshma Kewalramani,M.D.CEO and President2Safe Harbor Statement&Non-GAAP。

3、Teva Pharmaceutical Industries Ltd.January 13,20262|This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,which are based on。

4、Deepak Nath Ph.D.Chief Executive OfficerJP Morgan Healthcare Conference January 20261Forward looking statements and non-IFRS measuresThis document may contain forward-looking statements that may or m。

5、 2026 Revolution Medicines,Inc.On Target to Outsmart Cancer44th Annual JP Morgan Healthcare ConferenceJanuary 12,20262Legal DisclaimerThis presentation contains forward-looking statements within the 。

6、INTERNAL USE ONLYOlympus Corporate StrategyWhere Purpose Meets PerformanceJP Morgan ConferenceJanuary 13,20262 2Disclaimer This material contains forward-looking statements that reflect managements c。

7、Ready for the Next Wave of Growth1CMD 202444th annual J.P.Morgan Healthcare conferenceMerck Beln Garijo,CEOSan Francisco January 12,2026Strong Cash Generation as Backbone for M&AMaximizing opport。

8、J.P.Morgan 2026 Healthcare ConferencePTC Therapeutics 2026Matthew B.Klein,MDCEO J.P.Morgan 2026 Healthcare ConferenceJ.P.Morgan 2026 Healthcare ConferenceFDA and EMA approvals of SephienceAdvancement。

9、 2026 Henlius.Henlius(2696.HK)Company IntroductionDr.Jason Zhu,CEO&Executive DirectorJanuary 2026 2026 Henlius.Shanghai Henlius Biotech,Inc.(the“Company”,together with its subsidiaries,the“Group”。

10、 2026 GE HealthCare.GE is a trademark of General Electric Company used under trademark license.44thAnnual J.P.Morgan Healthcare ConferenceJanuary 13,2026 2026 GE HealthCare.GE is a trademark of Gener。

11、J.P.Morgan Healthcare ConferenceJeff SimmonsPresident&CEOJanuary 13,2026Notices and DisclaimersForward-Looking Statements.This presentation contains forward-looking statements within the meaning 。

12、JANUARY 2026Beyond Innovation to Impact:Building the Premier Endocrinology BusinessJ.P.Morgan Healthcare ConferenceAngela Living with AcromegalyForward Looking Statements and Legal DisclaimersForward。

13、JP Morgan Healthcare Conference 2025Mike Mahoney,Chairman and Chief Executive Officer2This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 。

14、Redefining Molecular Diagnostics with Single-Molecule PrecisionJPM Healthcare Conference 20262025 Q3 Business UpdateThis presentation contains certain“forward-looking statements within the meaning of。

15、2026 ASTELLAS PHARMA INC.AND ITS AFFILIATES.Astellas Pharma Inc.J.P.Morgan Healthcare Conference 2026Naoki OkamuraPresident and CEOJanuary 12th,2026Outcomesthat matter to patientsCostto the healthcar。

16、J.P.Morgan Healthcare Conference 2026Agios Pharmaceuticals Brian Goff,Chief Executive Officer14 January 2026 Forward-Looking Statements2This presentation and various remarks we make during this prese。

17、NASDAQ:XENExenon-Corporate Overview2026 J.P.MORGAN HEALTHCARE CONFERENCEJANUARY 2026Forward Looking Statement/Safe HarborThis slide presentation and the accompanying oral commentary contain forward-l。

18、J.P.Morgan 44th Annual Healthcare ConferenceUdit Batra,Ph.D.President&CEOJanuary 12,202612026 Waters CorporationForward-Looking Statements&Non-GAAP Financial MeasuresForward-Looking Statement。

19、 2026.Zai Lab.All Rights Reserved.NASDAQ:ZLAB|HKEX:9688Executing a Dual-Engine Growth Strategy44th Annual J.P.Morgan Healthcare Conference 2026Forward-Looking StatementsThis presentation contains for。

20、Turning Strategy into ResultsJean-Christophe Tellier,CEO44th Annual J.P.Morgan Healthcare Conference January 14th,20262Proprietary Property of UCBUCB 44th Annual J.P.Morgan Healthcare Conference|14th。

21、香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。WUXI XDC CAYMAN INC.（於開曼群島註冊成立的有限公司）（股份代號：2268）藥明合聯生物技術有限公司*內幕消息2026年醫療健康年會簡報本公告由藥明合聯生。

22、TAKING ON MSTG Therapeutics(NASDAQ:TGTX)Presenter:Michael S.Weiss,Chairman&CEO January 2026J.P.Morgan Healthcare Conference Forward Looking Safe Harbor Statement2This presentation contains forwar。

23、NoImageNoImage2026 J.P.Morgan Healthcare ConferenceRand Sutherland,MD,Chief Executive OfficerJanuary 2026 2026 Upstream Bio,Inc.NoImageNoImageNoImageNoImageThis presentation contains forward-looking 。

24、The next wave of targeted therapies in oncologyJP Morgan Healthcare ConferenceJanuary 12,2026Disclaimer and safe harbor statementCertain statements in this presentation may be considered forward-look。

25、 2026 Sotera Health Company|All Rights Reserved.2026 J.P.Morgan Healthcare ConferenceSafeguarding Global HealthMichael B.Petras,Jr.Chairman and Chief Executive OfficerJanuary 12,2026 2026 Sotera Heal。

26、Waleed Hassanein,MDPresident&CEO January 2026Establishing the New Standard of Care for Organ Transplantation 2Cautionary Note Regarding Forward Looking Statements This presentation contains forwa。

27、144th Annual J.P.Morgan Healthcare Conference JANUARY 2026ERIC LEFKOFSKY2DisclaimerThis presentation contains forward-looking statements that reflect Tempus AI,Inc.s(the“Company”or“Tempus”)current ex。

28、 Rhythm Pharmaceuticals,Inc.All rights reserved.Rhythm PharmaceuticalsCorporate PresentationJanuary 2026 2This presentation and the accompanying oral presentation contain forward-looking statements w。

29、44th Annual J.P.MorganHealthcare ConferenceJanuary 12,2026BOB DUGGANChairman&Co-Chief Executive OfficerDR.MAKY ZANGANEHPresident&Co-Chief Executive OfficerForward Looking StatementAny stateme。

30、January 2026NASDAQ:PGEN2Forward-looking StatementThis presentation contains“forward-looking”statements within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform 。

31、This presentation contains certain forward-looking statements.These forward-looking statements may be identified by words such as believes,expects,anticipates,projects,intends,should,seeks,estimates,。

32、Novartis growth storyVas Narasimhan,CEOJ.P.Morgan Healthcare ConferenceJanuary 12,2026DisclaimerNovartis growth story|January 12,20262Cautionary Statement Regarding Forward-Looking Statements This pr。

33、1J.P.Morgan Healthcare ConferenceJanuary 12,2026Christian Henry,President and CEO2Forward-looking statementsAll statements in this presentation(and any accompanying oral presentation)that are not his。

34、Property of InventivaAdvancing Lanifibranor:Potential Best-in-Disease Oral Therapy for MASHA DIFFERENTIATED ORAL ANTIFIBROTIC CANDIDATE DESIGNED TO ADDRESS PROGRESSIVE FIBROSIS IN F2/F3 MASHJ.P.Morga。

35、Extending the Boundaries of Targeted Cancer TherapiesPatrick Amstutz,CEOJanuary 2026 Nasdaq,SIX Swiss Exchange:MOLNDisclaimerThis presentation contains forward looking statements.Any statements conta。

36、Ypsomed 44th Annual J.P.Morgan Healthcare ConferenceTransforming selfcare,Transforming YpsomedSamuel Knzli(CFO)San Francisco,15 January 2026|PUBLICImportant informationThe information contained in th。

37、 Copyright 2026 Krystal Biotech,Inc.All rights reserved.Genetic Medicines for High Unmet Medical Needs JPM 2026Krystal|2Forward Looking Statements and DisclosuresForward Looking Statements This prese。

38、1Immunome Corporate Presentation44th Annual J.P.Morgan Healthcare ConferenceJanuary 20262DisclosuresFor purposes of this notice,the“presentation”that follows shall mean and include the slides that fo。

39、J.P.Morgan Healthcare ConferenceJanuary 13,2026Wave Life Sciences2Forward-looking statementsThis document contains forward-looking statements.All statements other than statements of historical facts 。

40、United Therapeutics CorporationJ.P.Morgan Healthcare ConferenceJANUARY 12,20262Safe Harbor StatementUTHR:A Public Benefit CorporationMIROKIDNEY,MIROLIVER,MIROLIVERELAP,ORENITRAM,REMODULIN,TYVASO,TYVA。

41、The world leader in serving scienceThe world leader in serving scienceMarc N.CasperChairman,President and Chief Executive OfficerJ.P.Morgan Healthcare ConferenceJanuary 13,20261Safe Harbor/Non-GAAP M。

42、J.P.Morgan Healthcare Conference PresentationDr.Christian BehrenbruchManaging Director and Group CEO12 January 2026ASX:TLX|NASDAQ:TLXThis presentation should be read together with our risk factors,as。

43、 COPYRIGHT 2026|STOKE THERAPEUTICS|COPYRIGHT 2026|STOKE THERAPEUTICS|1Stoke Therapeutics NASDAQ:STOKIan F.SmithChief Executive Officer and Director44th Annual J.P.Morgan Healthcare Conference January。

44、Pioneering access for patientsRichard Saynor,CEOJ.P.Morgan Healthcare ConferenceJanuary 2026DisclaimerThis presentation contains forward-looking statements,which offerno guarantee with regard to futu。

45、J.P.Morgan44thHealthcare ConferencePrahlad SinghChief Executive OfficerJanuary 13,2026Safe Harbor2This presentation contains forward-looking statements within the meaning of the Private Securities Li。

46、1Delivering on the promise of Prime EditingCorporate PresentationJanuary 20262This presentation contains forward-looking statements of Prime Medicine,Inc.(Prime,we or our)within the meaning of the Pr。

47、 2026 NOVAVAX.All rights reserved.1Novavax Corporate PresentationJohn C.Jacobs,President and Chief Executive OfficerJ.P.Morgan Healthcare Conference 2026 NOVAVAX.All rights reserved.1 2026 NOVAVAX.Al。

48、Leading the Fight Against MASHJanuary 12,2026J.P.Morgan 44th Annual Healthcare Conference Bill Sibold,Chief Executive OfficerDave Soergel,M.D.,Chief Medical Officer Forward-looking StatementsThis pre。

展开阅读全文

Es****e...

该用户很懒，什么也没介绍

摩根大通医疗保健大会 2026（JPM2026）演讲PPT合集（共158套打包）

报告合集目录

报告预览

相关合集

其他合集